At a glance
ClinicalIndex Comparison RecordN/ACompleted· 145 enrolled
Drug / intervention
ACUVUE OASYS 1-Day +5 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of Contact Lenses With UV/HEV-Filter on Visual Function
In Brief
A clinical study evaluating ACUVUE OASYS 1-Day, ACUVUE OASYS MAX 1-Day, and 4 other interventions for Visual Acuity. Completed, enrolled 145 participants across 1 site.
Detailed Summary
This is a 2-phase, single-site, non-dispensing, randomized, controlled, double-masked, 2x2 crossover study to objectively measure potential benefits of a new UV/HEV filter using psychophysical testing techniques.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedNov 2022
Enrollment StartDec 2022
Primary CompletionNov 2023
TodayJul 2026
First PostedNov 1, 2022
Enrollment StartDec 9, 2022
Primary CompletionNov 17, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.7 years ago
Interventions
ACUVUE OASYS 1-Daydevice
Sphere CONTROL
ACUVUE OASYS MAX 1-Daydevice
Sphere TEST
ACUVUE OASYS Multifocaldevice
Multifocal CONTROL
ACUVUE OASYS MAX 1-Day Multifocaldevice
Multifocal TEST
ACUVUE OASYS 1-Day for Astigmatismdevice
Toric CONTROL
senofilcon A based contact lens (toric) with new UV/HEV filterdevice
Toric TEST